ArticleCardiovascular diabetology2025
Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and all-cause mortality in type 1 diabetes.
Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeme oxygenase 1 (HO-1), encoded by the HMOX1 gene is a highly inducible enzyme with multiple cardiovascular protective properties. Polymorphisms of the HMOX1 gene, especially a guanine-thymine dinucleotide repeat polymorphism (GTn), affects its transcriptional activity and is associated with cardiovascular complications in the general population. We studied the association of HMOX1 polymorphisms and HO-1 serum concentrations with vascular complications and all-cause mortality in individuals with type 1 diabetes (T1D).
methodsThe study population consists of individuals with T1D participating in the Finnish Diabetic Nephropathy Study (FinnDiane). We genotyped the HMOX1 GTn repeat (n = 3990), extracted from genome-wide genotyping data two single nucleotide polymorphisms (SNPs) (-413A/T upstream variant rs2071746, and + 99G/C p.Asp7Asn missense variant rs2071747; n = 4278), and measured the serum HO-1 concentrations (n = 861) from blood samples taken during their study visit. The GTn repeats were divided into short (S) and long (L) alleles where the cutoff point was L ≥ 30 repeats.
resultsIn men, the LL genotype was associated with ischemic cardiac events (LL 22.9% vs. SS/SL 17.0%, p = 0.001) and all-cause mortality (p = 0.031). The association was detected in all individuals (LL 19.5% vs. SS/SL 16%, p = 0.006) but not in women (LL 15.7% vs. SS/SL 14.9%, p = 0.657). For the -413A/T SNP, men with the AA genotype experienced ischemic cardiac events more frequently (21.0% vs. 17.4%, p = 0.044), but no differences were found for women or for men and women together. There were no differences between different genotypes of the + 99G/C variant regarding cardiovascular complications. Also, there was no difference in HO-1 serum concentrations between different genotypes (GTn repeat, -413A/T or + 99G/C). Men had higher HO-1 serum concentrations compared to women (3.12 ± 1.23 ng/ml vs. 2.64 ± 1.04 ng/ml, p < 0.001). In women, higher HO-1 serum concentrations were associated with cardiovascular disease and need for antihypertensive and lipid lowering medications.
conclusionsThe LL genotype of the HMOX1 GTn repeat and the AA genotype of -413A/T SNP were associated with ischemic cardiac complications and all-cause mortality in men, but not in women. Thus, the HMOX1 genotype may influence the development of cardiovascular complications in individuals with T1D in a sex-dependent manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.